Instylla delivers next-generation liquid embolics for interventional radiology focused on interventional oncology and peripheral hemostasis.
Location: United States, Massachusetts, Bedford
Employees: 11-50
Total raised: $55.4M
Founded date: 2017
Investors 3
Date | Name | Website |
- | Excelestar... | excelestar... |
- | Ascension ... | ascensionv... |
- | Catalyst H... | chv.vc |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
26.08.2023 | - | $30M | - | finsmes.co... |
15.10.2020 | Series B | $25.4M | - | finsmes.co... |
Mentions in press and media 7
Date | Title | Description | Source |
26.08.2023 | Instylla Announces $30M Funding | BEDFORD, MA, Instylla, a company developing next-generation liquid embolics, announced the closing... | vcnewsdail... |
16.08.2023 | Instylla Closes $30M Equity Financing | Instylla, Inc., a Bedford, MA-based company developing next-generation liquid embolics for periphera... | finsmes.co... |
30.03.2021 | Instylla Announces Enrollment of Initial Patients in the Emb... | BEDFORD, Mass., March 30, 2021 /PRNewswire/ -- Instylla, Inc., a privately held company developing... | prnewswire... |
15.10.2020 | Instylla Scores $25.4M Series B Financing | BEDFORD, MA, Instylla has announced a $25.4 million Series B financing. >> Click here for m... | vcnewsdail... |
15.10.2020 | Instylla Closes $25.4M Series B Financing | Instylla, Inc., a Bedford, Mass.-based company developing minimally invasive liquid embolic products... | finsmes.co... |
14.10.2020 | Instylla Closes $25.4M Series B Financing | Instylla, Inc., a privately held company developing minimally invasive liquid embolic products desig... | citybizlis... |
- | Instylla | “Instylla delivers next-generation liquid embolics for interventional radiology focused on intervent... | fastfounde... |